General Information of Drug Inactive Ingredient (DIG) (ID: E00225)

DIG Name
Potassium citrate
Synonyms
Potassium citrate; TRIPOTASSIUM CITRATE; 866-84-2; Potassium citrate anhydrous; 7778-49-6; Potassiumcitrate; Citric acid, tripotassium salt; UNII-86R1NVR0HW; 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, tripotassium salt; 86R1NVR0HW; Kaliksir; CHEBI:64733; Citric acid, potassium salt; tripotassium 2-hydroxypropane-1,2,3-tricarboxylate; tripotassium;2-hydroxypropane-1,2,3-tricarboxylate; Litocit; Porekal; Kajos; Polycitra K; Urocit K; Seltz-K; C6H5K3O7; K citrate; 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, potassium salt (1:3); Potassium tribasic citrate; tripotassium citrate anhydrous; ACALKA; CCRIS 6566; HSDB 1248; EINECS 212-755-5; Potassium Citrate (anhydrous); EINECS 231-905-0; tri potassium citrate; 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, potassium salt; potassium citrate (anh.); anhydrous potassium citrate; EC 212-755-5; tripotassium citrate (anh.); anhydrous tripotassium citrate; INS NO.332(II); CHEMBL1200458; DTXSID8027325; tripotassium citrate (anhydrous); INS-332(II); 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, potassium salt (1:?); E-332(II); citric acid tripotassium salt (anh.); AKOS015918285; DB09125; citric acid tripotassium salt (anhydrous); E332; K544; Q781; FT-0653076; 1334-EP2380568A1; potassium 2-hydroxypropane-1,2,3-tricarboxylate; A841790; Q419921; tripotassium 2-oxidanylpropane-1,2,3-tricarboxylate
DIG Function
Alkalizing agent; Buffering agent; Complexing agent
Formula
C6H5K3O7
Canonical SMILES
C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[K+].[K+].[K+]
InChI
1S/C6H8O7.3K/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;/q;3*+1/p-3
InChIKey
QEEAPRPFLLJWCF-UHFFFAOYSA-K
Physicochemical Properties Molecular Weight 306.39 Topological Polar Surface Area 141
XlogP N.A. Complexity 211
Heavy Atom Count 16 Rotatable Bond Count 2
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 7

Full List of Drug(s) Co-administrated with This DIG

2 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Betamethasone DMAHJEF Acute adrenal insufficiency [] Betamethasone Valerate 0.12% aerosol F23643
Diphenhydramine DMKQTBA Hyperemesis gravidarum [] Diphenhydramine 12.5 mg tablet F06241
------------------
1 Clinical Trial Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Impoyz DMB1N6P Scalp dermatosis [] Clobetasol Propionate 0.05% aerosol F23047
------------------